Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Fernández

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
ACS Medicinal Chemistry Letters|September 16, 2020
Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic OpportunityAriel Fernández
ACS Pharmacology & Translational Science|June 21, 2021
Artificial Intelligence Set to Reverse Engineer Drug Targeting in the CellAriel Fernández
ACS Pharmacology & Translational Science|February 22, 2021
Glycosylation of SARS-CoV-2 Steers Evolutionary Outcomes in the Postvaccination PhaseAriel Fernández
The Journal of Chemical Physics|January 7, 2005
Buffering the entropic cost of hydrophobic collapse in protein chainsAriel Fernández
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|March 17, 2004
Lower limit to the size of the primeval amino acid alphabetAriel Fernández
Expert Opinion on Drug Discovery|November 30, 2018
Drug-based cancer therapy to overcome immune resistance by steering tumor evolutionAriel Fernández
Journal of Chemical Information and Modeling|November 19, 2019
Artificial Intelligence Steering Molecular Therapy in the Absence of Information on Target Structure and RegulationAriel Fernández
Journal of Biomolecular Structure & Dynamics|May 25, 2002
How do we probe ubiquitin's pathway heterogeneity?Ariel Fernández
Plos Computational Biology|November 14, 2007
Molecular basis for evolving modularity in the yeast protein interaction networkAriel Fernández
Idrugs : the Investigational Drugs Journal|October 1, 2009
Target Discovery--Select Biosciences' World Congress. 4-5 August 2009, San Francisco, CA, USAAriel Fernández
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
ACS Medicinal Chemistry Letters|September 16, 2020
Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic OpportunityAriel Fernández
ACS Pharmacology & Translational Science|June 21, 2021
Artificial Intelligence Set to Reverse Engineer Drug Targeting in the CellAriel Fernández
ACS Pharmacology & Translational Science|February 22, 2021
Glycosylation of SARS-CoV-2 Steers Evolutionary Outcomes in the Postvaccination PhaseAriel Fernández
The Journal of Chemical Physics|January 7, 2005
Buffering the entropic cost of hydrophobic collapse in protein chainsAriel Fernández
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|March 17, 2004
Lower limit to the size of the primeval amino acid alphabetAriel Fernández
Expert Opinion on Drug Discovery|November 30, 2018
Drug-based cancer therapy to overcome immune resistance by steering tumor evolutionAriel Fernández
Journal of Chemical Information and Modeling|November 19, 2019
Artificial Intelligence Steering Molecular Therapy in the Absence of Information on Target Structure and RegulationAriel Fernández
Journal of Biomolecular Structure & Dynamics|May 25, 2002
How do we probe ubiquitin's pathway heterogeneity?Ariel Fernández
Plos Computational Biology|November 14, 2007
Molecular basis for evolving modularity in the yeast protein interaction networkAriel Fernández
Idrugs : the Investigational Drugs Journal|October 1, 2009
Target Discovery--Select Biosciences' World Congress. 4-5 August 2009, San Francisco, CA, USAAriel Fernández
Pageof 14